ADAPTIVE BIOTECHNOLOGIES CORPORATION Shares Outstanding (Cover Page)
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) had Shares Outstanding (Cover Page) of 159.60 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 159.60M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 160.04M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 153.98M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 152.67M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 159.60M shares 10-Q · filed 2026-08-04 |
| 2026-04-30 | 160.04M shares 10-Q · filed 2026-05-05 |
| 2026-02-20 | 153.98M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 152.67M shares 10-Q · filed 2025-11-05 |
| 2025-07-31 | 152.27M shares 10-Q · filed 2025-08-05 |
| 2025-04-24 | 151.92M shares 10-Q · filed 2025-05-01 |
| 2025-02-26 | 148.58M shares 10-K · filed 2025-03-03 |
| 2024-11-04 | 147.58M shares 10-Q · filed 2024-11-07 |
| 2024-07-29 | 147.47M shares 10-Q · filed 2024-08-01 |
| 2024-05-02 | 147.37M shares 10-Q · filed 2024-05-07 |
| 2024-02-23 | 145.09M shares 10-K · filed 2024-02-29 |
| 2023-11-03 | 144.77M shares 10-Q · filed 2023-11-09 |
| 2023-07-28 | 144.65M shares 10-Q · filed 2023-08-02 |
| 2023-04-28 | 144.31M shares 10-Q · filed 2023-05-03 |
| 2023-02-09 | 143.23M shares 10-K · filed 2023-02-14 |
| 2022-10-28 | 143.01M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 142.87M shares 10-Q · filed 2022-08-03 |
| 2022-04-29 | 142.23M shares 10-Q · filed 2022-05-04 |
| 2022-02-10 | 141.58M shares 10-K · filed 2022-02-15 |
| 2021-10-29 | 141.13M shares 10-Q · filed 2021-11-03 |
| 2021-07-30 | 140.77M shares 10-Q · filed 2021-08-04 |
| 2021-04-30 | 140.31M shares 10-Q · filed 2021-05-05 |
| 2021-02-19 | 139.22M shares 10-K · filed 2021-02-24 |
| 2020-10-31 | 136.77M shares 10-Q · filed 2020-11-10 |
| 2020-07-31 | 135.79M shares 10-Q · filed 2020-08-10 |
| 2020-04-30 | 126.89M shares 10-Q · filed 2020-05-12 |
| 2020-02-21 | 126.32M shares 10-K · filed 2020-02-26 |
| 2019-10-31 | 124.34M shares 10-Q · filed 2019-11-12 |
| 2019-07-31 | 124.29M shares 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |